Leila Khoja
Queen Elizabeth Hospital Birmingham(GB)Bayer (Germany)(DE)University of Birmingham(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cancer Genomics and Diagnostics, Ocular Oncology and Treatments, Melanoma and MAPK Pathways
Most-Cited Works
- → Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review(2017)898 cited
- → Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study(2019)271 cited
- → A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker(2011)252 cited
- → Pembrolizumab(2015)220 cited
- → AR Signaling and the PI3K Pathway in Prostate Cancer(2017)166 cited
- → Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non–Small-Cell Lung Cancer(2018)142 cited